Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

被引：0
作者：
A. M. Peiró
M. Farré
P. N. Roset
M. Carbó
M. Pujadas
M. Torrens
J. Camí
R. de la Torre
机构：
[1] IMIM-Hospital del Mar Medical Research Institute,Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme
[2] Universitat Autònoma de Barcelona (UDIMAS-UAB),CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03)
[3] Universitat Pompeu Fabra (CEXS-UPF),undefined
[4] Addiction Unit - INAD,undefined
[5] Doctor Aiguader 88,undefined
[6] CIBEROBN,undefined
来源：
Psychopharmacology | 2013年 / 225卷
关键词：
MDMA; Ecstasy; Repeated dose; Humans; Metabolic inhibition; Pharmacologic effects; Pharmacokinetics; CYP2D6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 893
页数：10
相关论文
共 50 条
  • [21] Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users
    Parrott, A. C.
    Milani, R. M.
    Gouzoulis-Mayfrank, E.
    Daumann, J.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) : 959 - 968
  • [22] Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons
    Goodwin, Amy K.
    Mueller, Melanie
    Shell, Courtney D.
    Ricaurte, George A.
    Ator, Nancy A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (03) : 342 - 353
  • [23] Functional consequences of repeated (±)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys
    Taffe, MA
    Weed, MR
    Davis, S
    Huitrón-Resendiz, S
    Schroeder, R
    Parsons, LH
    Henriksen, SJ
    Gold, LH
    NEUROPSYCHOPHARMACOLOGY, 2001, 24 (03) : 230 - 239
  • [24] Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse
    Dinis-Oliveira, Ricardo Jorge
    Caldas, Ines
    Carvalho, Felix
    Magalhaes, Teresa
    CLINICAL TOXICOLOGY, 2010, 48 (08) : 863 - 864
  • [25] Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
    Wunderli, Michael D.
    Vonmoos, Matthias
    Treichler, Lorena
    Zeller, Carmen
    Dziobek, Isabel
    Kraemer, Thomas
    Baumgartner, Markus R.
    Seifritz, Erich
    Quednow, Boris B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (04) : 333 - 344
  • [26] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [27] Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys
    Michael A Taffe
    Michael R Weed
    Sophia Davis
    Salvador Huitrón-Resendiz
    Richard Schroeder
    Loren H Parsons
    Steven J Henriksen
    Lisa H Gold
    Neuropsychopharmacology, 2001, 24 : 230 - 239
  • [28] The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences
    Wyeth, Richard P.
    Mills, Edward M.
    Ullman, Alison
    Kenaston, M. Alexander
    Burwell, Johanna
    Sprague, Jon E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) : 33 - 38
  • [29] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    Psychopharmacology, 2011, 217 : 475 - 484
  • [30] Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
    Dafters, RI
    Duffy, F
    O'Donnell, PJ
    Bouquet, C
    PSYCHOPHARMACOLOGY, 1999, 145 (01) : 82 - 90
12345